Podcast Episodes
Back to Search
Incorporating miRNAs into a taRNA vector platform with Drs. Tim Beissert and Ayşegül Yildiz - The Molecular Therapy Podcast
Drs. Ayşegül Yildiz and Tim Beissert join Dr. Paloma Giangrande to discuss a recent article published in Molecular Therapy Nucleic Acids by Drs. Yild…
1 year, 2 months ago
Trust, Innovation, and the Power of Patient Advocacy with Brendan Hayes - ASGCT's The Issue
Join host Emily Walsh Martin and guest Brendan Hayes, senior director of education and innovative therapies at the National Bleeding Disorders Founda…
1 year, 3 months ago
Setting Safety Parameters in Gene Therapy Trials with Thomas Wechsler – The Issue
Today's episode takes us into crucial territory where science meets ethics in gene therapy development. Following our recent compelling conversation …
1 year, 4 months ago
RNA Exon Editing with Ascidian Therapeutics' Drs. Robert Bell and Michael Ehlers - The Molecular Therapy Podcast
Join Dr. Paloma Giangrande, Editor-in-Chief of Molecular Therapy Nucleic Acids, as she discusses RNA exon editing with Ascidian Therapeutics' leaders…
1 year, 4 months ago
Cell Therapy Development for Solid Tumors with AffyImmune's Sonal Gupta, MD, PhD - The Issue
Sonal Gupta, MD, PhD, SVP and Head of Clinical Development at Affyimmune Therapeutics talks with host Emily Walsh Martin, PhD, to explore the challen…
1 year, 5 months ago
Single-chain Antibody-directed Herpes Simplex Viruses with Joseph Glorioso, PhD - The Molecular Therapy Podcast
This episode features a conversation between Dr. Timothy Cripe and Dr. Joseph Glorioso, who discuss an article published in Molecular Therapy Oncolog…
1 year, 5 months ago
cGMP and Building Cohesive Teams with Christopher Choi, PhD, Roswell Park Comprehensive Cancer Center - The Issue
Host Emily Walsh Martin, PhD, is joined by Chris Choi, PhD, Roswell Park Comprehensive Cancer Center's Senior Vice President of Industry Partnerships…
1 year, 6 months ago
A New Era of Molecular Therapy with Joseph Glorioso, PhD
This episode features a conversation between Dr. Roland Herzog and Dr. Joseph Glorioso. On January 1, 2025, Dr. Glorioso will begin his 5-year term a…
1 year, 6 months ago
Non-AAV, Non-rare Gene Therapy with Derek Jackson, Pacira BioSciences–The Issue
Derek Jackson, vice president of cell and gene therapy product development at Pacira BioSciences, joins The Issue to take the program in a different …
1 year, 7 months ago
The Intersection of Ethics and Gene Therapy with Dr. Ben Hurlbut–The Issue
Dr. Ben Hurlbut, professor at Arizona State University's Lincoln Center for Applied Ethics, joins host Dr. Emily Walsh Martin for a critical conversa…
1 year, 8 months ago